Tracking the longitudinal course of physiologic and mental health functioning among individuals in substance use disorder treatment

IntroductionMental health monitoring is crucial to long-term recovery in substance use disorder (SUD) treatment; however, little is known about how changes in physiological indicators align with changes in self-reported mental health over time.MethodsWe examined longitudinal associations of resting heart rate (RHR) and heart rate variability (HRV) collected via a WHOOP® photoplethysmography device with self-reported stress, anxiety, and depressive symptoms among individuals in SUD treatment. Participants (N = 59) continuously wore the device and completed at least two mental health and stress assessments during the first month of residential treatment. ResultsLinear regression results indicated favorable changes in mental health and/or physiologic metrics, with notable heterogeneity in concurrent subject-level trends. Among participants with decreased RHR (better physiological functioning), 39% (N=23) also endorsed decreased stress, 42% (N=25) decreased anxiety, and 39% (N=23) improved depressive symptoms. Of those with increased HRV (greater stress adaptability), 39% (N=23) endorsed decreased stress, 39% (N=23) improved anxiety, and 41% (N=24) reduced depressive symptoms.DiscussionConcurrent changes in physiologic and mental health metrics during the first month of treatment varied across participants. These findings highlight the importance of integrating subjective mental health measures with physiological indicators to capture clinically relevant change during early SUD treatment.

STAT+: Wearables, and the flood of data they generate, inch closer to entering the clinic

A major selling point for wearable devices is the promise that they’ll help identify hidden health conditions before they lead to major harm. But a nagging issue has been the connection to clinician guidance when a smartwatch or ring raises the alarm.

To help address this issue, wearable makers Oura and Whoop recently announced they’ll make it possible for users to connect virtually with doctors directly from their apps. While the move could represent the first step in the long-awaited adoption of consumer health data by traditional clinical care, experts cautioned that the bar for data in clinical decision-making is higher than for simple wellness purposes. The Food and Drug Administration has only authorized a handful of wearable features for clinical use, and the evidence base for using wearable data to inform medical care is nascent. Widespread use by clinicians will take considerably more work.

“This was an inevitable development,” said Ida Sim, a physician and professor at the University of California, San Francisco, who studies how to make best use of consumer health data. “We’ve got these sensors that have ostensibly valuable data … but we haven’t even begun to tap into the real clinical value.”

Continue to STAT+ to read the full story…

Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye

Conditions: Artifical Intelligence; Cataract; Pterygium; Keratopathy; Subconjunctival Hemorrhage; Conjunctivitis; Stye; Blepharitis; Entropion; Ectropion; Exophthalmos; Irregular Pupils; Conjunctival Concretions; Hyphema; Hypopyon; Corneal Transplant Status

Interventions: Device: Smartphone-based on-device artificial intelligence system for anterior segment eye disease screening

Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University

Recruiting

Edwards Lifesciences makes a simple change for a first-of-its-kind tricuspid valve

The first-of-its-kind Edwards Lifesciences Triformis Resilia doesn’t look all that different from the structural heart device developer’s other prosthetic valves, but a simple yet critical design change allows it to address an unmet patient need. Edwards earned FDA approval for Triformis Resilia in May 2026. It’s the first surgical valve designed for the tricuspid position.…

The post Edwards Lifesciences makes a simple change for a first-of-its-kind tricuspid valve appeared first on Medical Design and Outsourcing.